BIO International 2026: Strengthening Collaboration Across the LNP Development Ecosystem

BIO International 2026 provided an outstanding opportunity for the Phosphorex team to connect with innovators advancing the next generation of nucleic acid therapeutics and targeted drug delivery technologies.

Throughout the conference, we were proud to participate alongside our LNP Alliance partners—NOF Corporation, NeoSome Life Sciences, NanoImaging Services, and Envol Biomedical—to discuss how an integrated network of specialized expertise can help accelerate the development of lipid nanoparticle (LNP)-based therapeutics.

From formulation and lipid chemistry to nanoparticle characterization, preclinical evaluation, and nonclinical development, the Alliance offers complementary capabilities designed to help developers navigate the complex path from discovery through clinical translation.

A highlight of the week was hosting the LNP Alliance customer reception, which brought together clients, collaborators, and industry colleagues for an evening of networking and discussion. It was a great opportunity to strengthen existing relationships, meet new innovators, and exchange ideas on the future of advanced drug delivery.

Thank you to everyone who visited us during BIO and joined us at the reception. We appreciate the conversations, insights, and new connections made throughout the week and look forward to continuing to support the advancement of innovative LNP-based therapeutics.

We look forward to seeing everyone again at future industry events.